MedTrace Logo

Pre-hospital ECMO in Advanced Resuscitation in Patients With Refractory Cardiac Arrest. ( SUB30 )

NCT03700125 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2025-08-08

Study results available
· View outcomes & findings →

Summary

To establish whether a pre-hospital advanced physician/ paramedic cardiac arrest team that is ECMO capable can establish ECMO flow within 30 minutes of collapse. The Sub30 study will investigate the technical and logistical feasibility of instituting pre-hospital Extracorporeal Cardiopulmonary Resuscitation (ECPR) within 30 minutes of collapse for selected patients (n=6) in a geographical sector of Greater London. It will achieve this through a unique collaboration between the primary emergency dispatch and response services (London Ambulance Service NHS Trust, LAS), pre-hospital practitioners (LAS and London Air Ambulance) and clinicians in ECMO (Barts Health NHS Trust).

Conditions

  • Death, Sudden, Cardiac
  • Out-Of-Hospital Cardiac Arrest
  • Ventricular Fibrillation
  • Cardiopulmonary Arrest With Successful Resuscitation

Interventions

PROCEDURE

ECMO resuscitation

Extracorporeal Cardio-Pulmonary Resuscitation (ECPR) using ECMO within 30 minutes of cardiac arrest

Sponsors & Collaborators

  • Bodychillz Ltd

    collaborator INDUSTRY

  • Maquet Cardiopulmonary GmbH

    collaborator INDUSTRY

  • Stryker Nordic

    collaborator INDUSTRY

  • London's Air Ambulance Charity, Registered Charity (801013)

    collaborator UNKNOWN

  • Barts & The London NHS Trust

    lead OTHER

Principal Investigators

  • Simon Finney · Barts & The London NHS Trust

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-23
Primary Completion
2022-12-15
Completion
2022-12-15

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03700125 on ClinicalTrials.gov